Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 July 2002

Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives

Arnab Roy Chowdhury, Suparna Mandal, Bidyottam Mittra, Shalini Sharma, Sibabrata Mukhopadhyay, Hemanta K. Majumder

Med Sci Monit 2002; 8(7): BR254-260 :: ID: 13614

Abstract

Background: Betulinic acid, a naturally abundant, plant derived, pentacyclic triterpenoid possesses anti- HIV, anti-malarial and anti-inflammatory properties and has recently emerged as a potent
anti-tumor compound. This study explores the mode of action of betulinic acid on eukaryotic topoisomerase I and identifies the major functional group responsible along with more potent derivatives.
Material/Methods: Topoisomerase I relaxation activity was electrophoretically measured by the decreased mobility of the relaxed monomers followed by ethidium bromide staining. DNA cleavage was studied by electrophoretic separation of the nicked monomers from the relaxed and supercoiled monomers in presence of ethidium bromide. In-vivo DNA cleavage was studied in blasted mouse splenocytes by the SDS-K+ trapping of 3H-DNA-topoisomerase I-camptothecin ternary complex.
Results: Betulinic acid exerts its inhibitory effect by preventing topoisomerase I-DNA interaction as a result of which the ‘cleavable complex’ is not formed. In consequence, it also acts as an antagonist
to camptothecin-mediated cleavage. A series of analogues modified at C-3, C-17 and C- 20 positions of betulinic acid were subsequently assayed for inhibition of topoisomerase I catalytic activity. Replacement of the 17-carboxylic group reduces the inhibitory effect and decarboxylation leads to the complete loss of inhibitory effect.
Conclusion: This study is the first detail report of betulinic acid as a very potent inhibitior of eukaryotic topoisomerase I and highlights the necessity of the carboxylic functional group. Dihydro betulinic acid is the most potent (IC50=0.5 µM) pentacyclic triterpenoid to inhibit eukaryotic topoisomerase I till date and can be exploited as a strong candidate for anti-tumor drug designing.

Keywords: Antineoplastic Agents, Phytogenic - chemistry, Antineoplastic Agents, Phytogenic - isolation & purification, Antineoplastic Agents, Phytogenic - metabolism, Camptothecin - metabolism, DNA - metabolism, DNA Topoisomerases, Type I, Eukaryotic - antagonists & inhibitors, DNA Topoisomerases, Type I, Eukaryotic - metabolism, DNA-Binding Proteins - metabolism, Enzyme Inhibitors - chemistry, Enzyme Inhibitors - isolation & purification, Enzyme Inhibitors - metabolism, Macromolecular Substances, Molecular Structure, Plant Extracts - chemistry, Plant Extracts - metabolism, Protein Binding, Triterpenes - chemistry, Triterpenes - isolation & purification, Triterpenes - metabolism

0 Comments

Editorial

01 December 2022 : Editorial  

Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.939088

Med Sci Monit 2022; 28:e939088

SARS-CoV-2/COVID-19

09 December 2022 : Database Analysis  

A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription–Polymerase Chain React...

Med Sci Monit In Press; DOI: 10.12659/MSM.938872  

10 December 2022 : Clinical Research  

Retrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...

Med Sci Monit 2022; 28:e938647

07 December 2022 : Clinical Research  

A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vacc...

Med Sci Monit 2022; 28:e938665

In Press

09 Dec 2022 : Clinical Research  

Factors for In-Hospital Mortality in 145 Male Patients with Fournier’s Gangrene: A 10-Year Observational St...

Med Sci Monit In Press; DOI: 10.12659/MSM.938578  

09 Dec 2022 : Database Analysis  

A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription–Polymerase Chain React...

Med Sci Monit In Press; DOI: 10.12659/MSM.938872  

09 Dec 2022 : Clinical Research  

Analysis of Serum Inflammatory Markers in Infants Under 6 Months of Age with Non-Syndromic Moderate and Sev...

Med Sci Monit In Press; DOI: 10.12659/MSM.938165  

09 Dec 2022 : Clinical Research  

Analysis of Risk Factors of Potentially Difficult Endotracheal Intubation: A Retrospective Observational St...

Med Sci Monit In Press; DOI: 10.12659/MSM.937965  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

01 Nov 2020 : Review article  

Long-Term Respiratory and Neurological Sequelae of COVID-19

DOI :10.12659/MSM.928996

Med Sci Monit 2020; 26:e928996

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750